| scholarly article | Q13442814 |
| P2093 | author name string | S N Georas | |
| R P Schleimer | |||
| S C Lee | |||
| S C Gilman | |||
| K M Leiferman | |||
| C Stellato | |||
| L A Beck | |||
| S Shahabuddin | |||
| T G Woodworth | |||
| M E Brummet | |||
| R P Gladue | |||
| P2860 | cites work | Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen | Q21999034 |
| Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha | Q24321555 | ||
| Human chemokines: an update | Q28237635 | ||
| Cloning, chromosomal localization, and RNA expression of a human beta chemokine receptor-like gene | Q28295734 | ||
| Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor | Q28297700 | ||
| Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids | Q28372702 | ||
| Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 | Q28591681 | ||
| Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
| Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis | Q34129985 | ||
| Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells | Q34444540 | ||
| Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. | Q35590538 | ||
| Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis | Q35821357 | ||
| Macrophage inflammatory protein-1 alpha activates basophils and mast cells | Q36231774 | ||
| RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes | Q36232134 | ||
| The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis | Q36350445 | ||
| Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8 | Q36362602 | ||
| Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. | Q36367109 | ||
| Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage | Q36380925 | ||
| Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury | Q37373611 | ||
| Expression and regulation of chemokines in bacterial pneumonia. | Q40943410 | ||
| Receptor-mediated endocytosis of CC-chemokines | Q41116346 | ||
| Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). | Q41466231 | ||
| Chemokines: what chemokine is that? | Q41510862 | ||
| ELAM-1 is an adhesion molecule for skin-homing T cells | Q41694765 | ||
| Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi) T cells after tight adhesion to human umbilical vein endothelial cell monolayers | Q41847767 | ||
| The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness | Q42417164 | ||
| MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions | Q42465419 | ||
| Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes | Q42941748 | ||
| A factor in human plasma permits persistent expression of E-selectin by human endothelial cells. | Q52058504 | ||
| Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β | Q52062623 | ||
| Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. | Q54005107 | ||
| Glycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines | Q57019212 | ||
| T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ | Q59068529 | ||
| T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis | Q68139847 | ||
| Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis | Q69897414 | ||
| Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding | Q71631203 | ||
| Early production of macrophage inflammatory protein-1 alpha occurs in respiratory distress syndrome and is associated with poor outcome | Q71671350 | ||
| C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation | Q71802253 | ||
| RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors | Q72072761 | ||
| Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production | Q72376935 | ||
| Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge | Q73885831 | ||
| MCP-1 and MIP-1alpha are most efficient in recruiting T cells into the skin in vivo | Q77695838 | ||
| Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics | Q93864382 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| macrophage | Q184204 | ||
| Fc fragment of IgG receptor IIIa | Q21101397 | ||
| C-C motif chemokine receptor 1 | Q21111916 | ||
| human subject research project | Q1331083 | ||
| C-C motif chemokine ligand 3 | Q5009623 | ||
| recruitment of neutrophils | Q106892816 | ||
| P304 | page(s) | 3392-401 | |
| P577 | publication date | 2000-03-15 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes | |
| P478 | volume | 164 |
| Q34130186 | Amelioration of rat adjuvant-induced arthritis by Met-RANTES. |
| Q35597448 | An ex vivo model for studying hepatic schistosomiasis and the effect of released protein from dying eggs |
| Q37683772 | Anti-chemokine small molecule drugs: a promising future? |
| Q41863783 | CC chemokines induce P-selectin-dependent neutrophil rolling and recruitment in vivo: intermediary role of mast cells |
| Q42605598 | CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases |
| Q39882857 | Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor. |
| Q79537106 | Chemokine signaling pathways in corneal fibroblasts |
| Q35746460 | Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin. |
| Q74263629 | Chemokines in human periodontal disease tissues |
| Q37394316 | Cognate antigen stimulation generates potent CD8(+) inflammatory effector T cells |
| Q44598110 | Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease. |
| Q46323881 | Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects. |
| Q56876471 | Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies |
| Q42516852 | Gingival epithelial cell expression of macrophage inflammatory protein-1alpha induced by interleukin-1beta and lipopolysaccharide |
| Q33664480 | Hepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cells |
| Q42834113 | Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines |
| Q58792332 | IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation |
| Q37733774 | Immunological differences and similarities between chronic periodontitis and aggressive periodontitis. |
| Q35755276 | Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease |
| Q35048821 | In situ binding assay for studying chemokine interactions with endothelial cells |
| Q34006551 | Interactions of Neisseria gonorrhoeae with mature human macrophage opacity proteins influence production of proinflammatory cytokines. |
| Q35988030 | Intratumoral immunotherapy: using the tumour against itself |
| Q35879709 | Lack of evidence for contact sensitization by Pfiesteria extract |
| Q28211059 | Macrophage inflammatory protein-1 |
| Q41939544 | Macrophage trafficking as key mediator of adenine-induced kidney injury. |
| Q36822184 | Manipulating the chemokine-chemokine receptor network to treat cancer |
| Q42427197 | Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice |
| Q33811066 | Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB. |
| Q37790697 | N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338 |
| Q90836112 | Neutrophil chemoattractant receptors in health and disease: double-edged swords |
| Q41603563 | Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo |
| Q40697276 | Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta |
| Q51465120 | Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715. |
| Q35027759 | Regulation of chemokine expression in atherosclerosis |
| Q36303451 | Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma |
| Q54565890 | Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytes. |
| Q77332357 | Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases |
| Q47618731 | The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs |
| Q54775460 | The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. |
| Q34125545 | The role of chemokines and chemokine receptors in mucosal inflammation. |
| Q40063162 | Ticks produce highly selective chemokine binding proteins with antiinflammatory activity |
| Q44479312 | Treatment with Met-RANTES reduces lung injury in caerulein-induced pancreatitis. |
| Q45251307 | Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis |
| Q42729185 | Unraveling the mechanism of action of a new type III secretion system effector AexU from Aeromonas hydrophila |
| Q28345267 | Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice |
Search more.